147 research outputs found
Standards and Related Regulations in International Trade: A Modeling Approach
Standards and technical regulations which govern the admissibility of imported goods into an economy raise costs of exporters entering new markets, and may have a particularly high impact on firms seeking to export from developing countries. Yet standards may also have a positive side, such as certifying product quality and safety for the consumer. This paper suggests approaches to modeling standards and technical regulations, with a particular concern that these approaches are at least potentially implementable in an applied general-equilibrium model with real data.
Exploring geometric morphology in shape memory textiles: design of dynamic light filters
Thermo-responsive Shape Memory Alloys are able to adopt a temporary configuration and return to their programmed
shape when heated to a determined activation temperature. The possibility to integrate them in textile substrates
creates potential to develop smart textiles whose shape change explores functional and expressive purposes.
The aim of this research is to develop shape memory woven textiles in which dynamic behavior achieves predefined
geometric shapes. The requirement of geometric morphology was addressed through origami techniques. Combining
foldability properties with shape change, it is possible to design textile structures with a variable number of layers.
Difference in light transmittance is analyzed according to layer variation. Experiments conducted explore methodological
processes aimed at future developments in dynamic light filters research. The results highlight a process to design textiles
with predefined geometric morphologies that can be activated electrically, and delineate a further study in order to
improve the shape memory textile behavior.This work was supported by FEDER funds through the
Operational Programme for Competitiveness Factors –
COMPETE and National Funds through FCT –
Foundation for Science and Technology (project SFRH/
BD/87196/2012) and FCT and FEDER-COMPETE (project
PEst-C/CTM/UI0264/2011)
Price regulation and parallel imports of pharmaceuticals
This paper studies the effects of price regulation and parallel imports in the onpatent
pharmaceutical market. First, we develop a theory model in which a pharmacy negotiates producer prices with a brand-name firm and then sets retail prices. We show that the effects of price regulation crucially depend on whether the producer faces competition from parallel imports. While parallel imports improve the bargaining position of the pharmacy, price regulation counteracts this effect and may even be profitable for the producer. Second, we use a unique dataset with information on
sales and prices at both producer and retail level for 165 substances over four years
(2004-7). Exploiting exogenous variation in the regulated price caps, we show that stricter price regulation reduces competition from parallel imports. While the effect is clearly negative on producer profits for substances without parallel imports, the effect is not significant for substances with parallel imports. Finally, we show that stricter price regulation reduces total expenditures, but the effect is much stronger for substances with parallel import. Thus, our results suggest that price regulation may promote both static and dynamic efficiency in the presence of parallel imports.COMPETE, QREN, FEDER, Fundação para a Ciência e a Tecnologia (FCT
Pharmaceutical Cost-Sharing Systems and Savings for Health Care Systems from Parallel Trade
Recommended from our members
Compulsory licensing and access to drugs
Compulsory licensing allows the use of a patented invention without the owner's consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it can be detrimental to innovation. We model the interaction between a company in the North that holds the patent for a certain drug and a government in the South that needs to purchase it. We show that both access to drugs and pharmaceutical innovation depend largely on the Southern country's ability to manufacture a generic version. If the manufacturing cost is too high, compulsory licensing is not exercised. As the cost decreases, it becomes a credible threat forcing prices down, but reducing both access and innovation. When the cost is low enough, the South produces its own generic version and access reaches its highest value, despite a reduction in innovation. The global welfare analysis shows that the overall impact of compulsory licensing can be positive, even when accounting for its impact on innovation. We also consider the interaction between compulsory licensing and the strength of intellectual property rights, which can have global repercussions in other markets beyond the South
Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases.
Postsurgical radiotherapy (RT) has been early proven to prevent local tumor recurrence, initially performed with whole brain RT (WBRT). Subsequent to disadvantageous cognitive sequalae for the patient and the broad distribution of modern linear accelerators, focal irradiation of the tumor has omitted WBRT in most cases. In many studies, the effectiveness of local RT of the resection cavity, either as single-fraction stereotactic radiosurgery (SRS) or hypo-fractionated stereotactic RT (hFSRT), has been demonstrated to be effective and safe. However, whereas prospective high-level incidence is still lacking on which dose and fractionation scheme is the best choice for the patient, further ablative techniques have come into play. Neoadjuvant SRS (N-SRS) prior to resection combines straightforward target delineation with an accelerated post-surgical phase, allowing an earlier start of systemic treatment or rehabilitation as indicated. In addition, low-energy intraoperative RT (IORT) on the surgical bed has been introduced as another alternative to external beam RT, offering sterilization of the cavity surface with steep dose gradients towards the healthy brain. This consensus paper summarizes current local treatment strategies for resectable brain metastases regarding available data and patient-centered decision-making
Diffuse glioma growth: a guerilla war
In contrast to almost all other brain tumors, diffuse gliomas infiltrate extensively in the neuropil. This growth pattern is a major factor in therapeutic failure. Diffuse infiltrative glioma cells show some similarities with guerilla warriors. Histopathologically, the tumor cells tend to invade individually or in small groups in between the dense network of neuronal and glial cell processes. Meanwhile, in large areas of diffuse gliomas the tumor cells abuse pre-existent “supply lines” for oxygen and nutrients rather than constructing their own. Radiological visualization of the invasive front of diffuse gliomas is difficult. Although the knowledge about migration of (tumor)cells is rapidly increasing, the exact molecular mechanisms underlying infiltration of glioma cells in the neuropil have not yet been elucidated. As the efficacy of conventional methods to fight diffuse infiltrative glioma cells is limited, a more targeted (“search & destroy”) tactic may be needed for these tumors. Hopefully, the study of original human glioma tissue and of genotypically and phenotypically relevant glioma models will soon provide information about the Achilles heel of diffuse infiltrative glioma cells that can be used for more effective therapeutic strategies
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
- …